Dexferrum is a drug owned by American Regent Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Sep 29, 2015. Details of Dexferrum's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5624668 | Iron dextran formulations |
Sep, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Dexferrum is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Dexferrum's family patents as well as insights into ongoing legal events on those patents.
Dexferrum's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Dexferrum's generic launch date based on the expiry of its last outstanding patent is estimated to be Sep 29, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Dexferrum Generics:
There are no approved generic versions for Dexferrum as of now.
About Dexferrum
Dexferrum is a drug owned by American Regent Inc. Dexferrum uses Iron Dextran as an active ingredient. Dexferrum was launched by Am Regent in 1996.
Approval Date:
Dexferrum was approved by FDA for market use on 23 February, 1996.
Active Ingredient:
Dexferrum uses Iron Dextran as the active ingredient. Check out other Drugs and Companies using Iron Dextran ingredient
Dosage:
Dexferrum is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 50MG IRON/ML | INJECTABLE | Discontinued | INJECTION |